AI Nexus for Early Disease Detection and Risk Prediction: Revolutionizing Healthcare through Intelligence
Journal of Technology and Systems · 18.06.2026 · 8 (2) · 15-28
DOI: 10.47941/jts.3791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Technology and Systems, online erschienen am 18.06.2026. Verfasst von Sadhasivam Mohanadas. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
This paper provides an evidence base and clinical context for the use of Artificial Intelligence (AI) for early disease detection and disease risk prediction. Methodology: For this evidence-based analysis, a literature-based analytical approach was used. For the analysis of the available publications, a search was conducted in PubMed/MEDLINE, IEEE Xplore, ACM Digital Library, and CrossRef. The search included only English-language, peer-reviewed publications between January 2021 and August 2025. A structured catalog of four key aspects was used to organize the found evidence: 1) a description of the clinical tasks that were analyzed using models; 2) model families; 3) a description of the used validation; 4) outcomes of the models (measures, etc.).
Findings
The analysis provides strong evidence that, in non-inferior or better terms than the current clinical screening workflows, AI can be used to overcome some of the limitations of the manual analysis of a patient’s data, such as subjectivity, delay, and information overload. However, new challenges also arise in interpreting the decisions produced by the AI system (as the computer arrived at them), given the possible presence of bias in the development datasets, and in the infrastructure needed to implement the different applications in clinical settings where they will be used. Unique Contribution to Theory, Policy and Practice: Health systems must prioritize the external validation of their AI models. Health systems and organizations must develop de-identified datasets that reflect the demographics of the patients and settings where the models will be used. Data sharing within and between organizations must occur using standardized protocols. Clinically used AI must be explainable, and health systems and organizations must require their developers to make their clinical AI tools explainable. Health IT is evolving rapidly, and corresponding regulatory frameworks must keep pace without putting patients at risk.
Zitieren
APA
Mohanadas, S. (2026). AI Nexus for Early Disease Detection and Risk Prediction: Revolutionizing Healthcare through Intelligence. Journal of Technology and Systems, 8(2), 15-28. https://doi.org/10.47941/jts.3791
Vancouver
Mohanadas S. AI Nexus for Early Disease Detection and Risk Prediction: Revolutionizing Healthcare through Intelligence. Journal of Technology and Systems. 2026;8(2):15-28. doi:10.47941/jts.3791
BibTeX
@article{Mohanadas2026,
author = {Mohanadas, Sadhasivam},
title = {AI Nexus for Early Disease Detection and Risk Prediction: Revolutionizing Healthcare through Intelligence},
journal = {Journal of Technology and Systems},
year = {2026},
volume = {8},
number = {2},
pages = {15--28},
doi = {10.47941/jts.3791}
}
EUVIMED